With several years of high-level experience, T. Daniel “Dan” Logan counsels clients on a variety of Food and Drug Administration (FDA) regulatory issues relating to the food, cosmetic, drug, dietary supplement, and tobacco company industries. Dan previously served as an Associate Chief Counsel in the Office of Chief Counsel of the FDA. In that role, Dan learned to navigate the intricacies of the Federal Food, Drug and Cosmetic Act, Administrative Procedure Act, Freedom of Information Act, and the Federal Advisory Committee Act, among others.

While at the FDA, Dan counseled subject matter experts, assessed evidence and policy rationales, and developed legal interpretations relating to FDA’s regulatory objectives. Additionally, during his time at the FDA, Dan worked with the Center for Tobacco Products and directed the center on rulemakings, program development, calculation and assessment of user fees, premarket review of tobacco products, and enforcement strategies. Dan also served as counsel for the FDA for investigations conducted by the Government Accountability Office and Office of the Inspector General of the Department of Health and Human Services.

Prior to joining Kleinfeld, Kaplan & Becker, Dan interned for the Hon. Sarah Evans Barker of the United States District Court for the Southern District of Indiana as well as the Hon. Mark Massa of the Indiana Supreme Court. He also interned at a medical device company and worked as a researcher in a molecular biology lab at the University of Pennsylvania’s Perelman School of Medicine, where he conducted research relating to the mechanisms of T-cell development and migration.

Dan was included in the 2023 and 2024 editions of the Best Lawyers: Ones to Watch® in America for his work in Administrative / Regulatory Law.